Introduction
============

Since 2011 a National Influenza Surveillance System in Vietnam has conducted SARI surveillance to collect information and inform control and prevention strategies.

Objectives
==========

To determine the burden of influenza related SARI by gender and age.

Methods
=======

Selected patients met the WHO\'s SARI definition (an acute respiratory infection with history of fever or measured temperature ≥38C°; cough onset within the last 10 days; and requires hospitalization), were enrolled at four hospitals. Demographic, clinical data and one respiratory swab specimen were collected. Specimens were tested by PCR for influenza virus.

Results
=======

From March 2011 to April 2013, a total of 2,876 SARI patients were enrolled. The median age was 16 years (IQR 1-34 years). Of all enrolled patients, 1392 (48.4%) were children \<15 years old and 1482 (51.5%) were male. 297 (10.3%) of 2,876 SARI cases were positive for influenza virus by RT-PCR. Positive rates by age group in years were 0 to \<5 (26.9%), 5 to \< 15 (1.7%), 15 to \<25 (19.5%), 25 to \<35 (25.3%), 35 to \<45 (7.7%), 45 to \<55 (6.7%), 55 to \<65 (3.4%) and ≥65 (8.8%). Of the 297 influenza positive samples, 145(48.8%) were B, 85 (28.6%) were A/H3N2, and 67 (22.6%) were A/H1N1pdm09. Among the influenza positive patients, 45 (15.1%) were hospitalized in the ICU. At least one underlying health condition was reported by 57 (19.2%) influenza positive patients included smoking, lung disease, diabetes, liver disease, heart disease, hypertension, neurologic disease and pregnancy.

Conclusion
==========

Influenza virus infection was identified as a cause of SARI in hospitalized patients in Vietnam. As a vaccine preventable disease, it remains a burden to the healthcare system as well as a burden to the patient and family. The 0 to \<5 and 25 to \<35 age groups were more affected with influenza, accounting for 52.2% of influenza positive cases. Additional studies may help to better define risk factors related to infection and disease severity, evaluate the use of influenza vaccine in reducing disease burden in Vietnam.
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